Premium
FDA seeks to encourage more research on cannabis compounds' health effects
Author(s) -
Enos Gary
Publication year - 2020
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.32792
Subject(s) - cannabis , food and drug administration , legislature , political science , business , public relations , medicine , psychology , pharmacology , psychiatry , law
Although federal legislative changes in recent years have created new opportunities for cannabis‐related clinical research, it remains unclear as to when — or even if — more drugs containing cannabis or cannabis‐derived compounds will eventually make it through the federal approval process. The Food and Drug Administration (FDA) on July 21 issued a draft guidance document for industry on cannabis‐related research, outlining a complexity of considerations that signal a challenging process for the research community.